eli lily glp-1 New clinical trial data from Lilly shows its daily weight loss pill can reduce body weight by up to 11% over time. ABC News medical correspondent Dr. Darien Sutton joins Linsey Davis to FDA approval for Zepbound (tirzepatide)

People taking GLP-1 drugs had fewer alcohol-related hospitalizations than people taking standard drugs for alcohol use disorder.

New regulations taking effect on 1 October 2024 will remove compounded semaglutide-containing products from the pharmacy compounding exemption

Discover online weight management program, with smart scale, expert coaches, and personalized plans.

A widely prescribed class of weight-loss and diabetes medications may be doing more than improving metabolic health.

Overnight oats are a delicious and convenient option for a diabetes-friendly breakfast that can support steady blood sugar levels.

Insulin resistance and chronic hyperglycemia cause a cascade of pathological events in the brain, including neuroinflammation, impaired neurotransmitter systems and energy metabolism, oxidative stress, and vascular pathologies that ultimately lead to neurodegeneration, loss of synaptic plasticity, brain aging, cognitive impairment, and dementia